Relation of in-hospital serum creatinine change patterns and outcomes among ST-segment elevation myocardial

Yacov Shacham1, Eran Leshem-Rubinow1, Amir Gal-Oz2

  • 1Department of Cardiology, Tel-Aviv University, Tel-Aviv, Israel.

Clinical Cardiology
|February 3, 2015
PubMed

Insights

In ST-segment elevation MI (STEMI) patients, worsening serum creatinine (sCr) after percutaneous coronary intervention (PCI) indicates poor outcomes. However, improved sCr levels post-PCI do not correlate with adverse events.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Worsening serum creatinine (sCr) is common in ST-segment elevation myocardial infarction (STEMI) patients after primary percutaneous coronary intervention (PCI), linked to poor outcomes.
  • The prognostic significance of improved sCr levels during hospitalization post-PCI remains unclear.

Purpose of the Study:

  • To investigate the incidence and prognostic implications of changes in sCr levels (worsening or improvement) during hospitalization in STEMI patients undergoing primary PCI.
  • To compare outcomes between patients with stable, worsened, or improved sCr levels.

Main Methods:

  • Retrospective study of 1260 STEMI patients who underwent primary PCI.
  • Categorization of patients based on sCr changes: stable, worsened (>0.3 mg/dL increase), or improved (>0.3 mg/dL decrease) from admission levels.
  • Comparison of in-hospital complications and long-term mortality across the sCr change groups.

Main Results:

  • 10% of patients experienced worsening sCr, while 3.5% showed improvement.
  • Worsening sCr was associated with increased in-hospital complications and significantly higher 30-day and 5-year mortality (HR 6.68).
  • No significant differences in complications or mortality were observed between patients with improved sCr and those with stable sCr.

Conclusions:

  • In STEMI patients undergoing primary PCI, worsening renal function (indicated by sCr increase) is a frequent finding with adverse prognostic implications.
  • Conversely, improvement in sCr levels during hospitalization is not associated with adverse short-term or long-term outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
803
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.0K